Vimarsana
Biggest News Aggregation in the World

Page 2 - Cell Line Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Line Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Line Development Today - Breaking & Trending Today

Monitoring the cause of antibody discoloration with cIEF - Vimarsana News

Monitoring the cause of antibody discoloration with cIEF

This technical note highlights a streamlined solution to monitor antibody discoloration using an EAD-based MAM workflow

Abzena launches new platforms to improve cell line efficiency - Vimarsana News

Abzena launches new platforms to improve cell line efficiency

Abzena, an end-to-end CDMO for biologics and bioconjugates, has launched AbZelect and AbZelectPRO cell line development (CLD) platforms to accelerate cell lie production for manufacturing antibodies and recombinant proteins.

Global Cell Line Development Market to Reach $14.7 Billion - Vimarsana News

Global Cell Line Development Market to Reach $14.7 Billion

Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The

Cell Line Development Industry Set to Reach US$ 4,674.8 Million by 2033, With a CAGR of 4.1% | FMI - Vimarsana News

Cell Line Development Industry Set to Reach US$ 4,674.8 Million by 2033, With a CAGR of 4.1% | FMI

The global Cell Line Development Industry is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 4.1% during the forecast period. According to the latest market insights, total cell line product sales are expected to reach US$ 3,124.4 million in 2023, and a staggering US$ 4,674.8...

Cell Line Development Market is anticipated to increase at a stable CAGR over the forecast period (2023 to 2029) - Vimarsana News

Cell Line Development Market is anticipated to increase at a stable CAGR over the forecast period (2023 to 2029)

The global Cell Line Development market is anticipated to grow at a CAGR of 9.6% during the forecast period (2023-2030).